Patents Assigned to BLODVERY PHARMATECH, LTD
  • Patent number: 10471013
    Abstract: The present disclosure disclosed a microsphere-producing process involving three integrated unit operations, 1) microspheres formation; 2) microsphere quality control; 3) post formation microsphere treatment. The first unit operation, i.e. unit operation 1) is integrated with four essential functions: forcing the particle forming materials to pass through a porous membrane to form embryonic micropsheres; enforcing the embryonic microspheres to detach the porous membrane; solidifying the embryonic microspheres; collecting and outputting the solidified microspheres. The quality control unit operation consists discrimination and ejection of oversized microspheres. The post treatment unit operation is integrated with two essential functions, smoothing the microsphere surfaces and reducing organic solvents trapped inside of microsphere matrix.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: November 12, 2019
    Assignee: BLODVERY PHARMATECH, LTD
    Inventor: Tuo Jin